• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SNT

SYNTARA LIMITED

1.47% ! 6.7¢
Market Cap $108.8M  !
Healthcare Biotechnology
Add to My Watchlist

Syntara Limited is an Australia-based clinical-stage drug development company. The... Syntara Limited is an Australia-based clinical-stage drug development company. The Company is targeting extracellular matrix dysfunction with its amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The Company’s lead candidate SNT-5505 is for the bone marrow cancer myelofibrosis which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its product candidate, SNT-4728, is an inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis and cardiac fibrosis.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SNT
Ann: New positive interim data in Phase 2 study of SNT-5505 		14/06/25 24 6.6K
14/06/25 Last post  Sharespike Comments Created with Sketch.  24  Views Created with Sketch.  6.6K 
SNT
Value of Syntara
2 3
14/06/25 142 39K
14/06/25 Last post  newB Comments Created with Sketch.  142  Views Created with Sketch.  39K 
SNT
Ann: EHA 2025 SNT-5505 Interim Data Webinar Presentation 		13/06/25 11 3.0K
13/06/25 Last post  SpiralNotebook Comments Created with Sketch.  11  Views Created with Sketch.  3.0K 
SNT
Comparative Value of SNT-5505 vs Marketed MF Drugs 		13/06/25 3 954
13/06/25 Last post  NZ Trader Comments Created with Sketch.  3  Views Created with Sketch.  954 
SNT
Ann: SNT-5505 interim Phase 2 data webinar 		13/06/25 0 304
13/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  304 
SNT
Ann: Application for quotation of securities - SNT 		11/06/25 2 902
11/06/25 Last post  newB Comments Created with Sketch.  2  Views Created with Sketch.  902 
SNT
Ann: SNT-5505 awarded US FDA Fast Track designation 		10/06/25 29 8.0K
10/06/25 Last post  newB Comments Created with Sketch.  29  Views Created with Sketch.  8.0K 
SNT
SNT - Broker DATA
2
10/06/25 91 28K
10/06/25 Last post  newB Comments Created with Sketch.  91  Views Created with Sketch.  28K 

See All Discussions arrow Created with Sketch.

Timeline

EHA 2025 SNT-5505 Interim Data Webinar Presentation
13 Jun 10:42
 
New positive interim data in Phase 2 study of SNT-5505
13 Jun 08:36
 
SNT-5505 interim Phase 2 data webinar
13 Jun 08:26
 
Application for quotation of securities - SNT
10 Jun 16:25
 
SNT-5505 awarded US FDA Fast Track designation
10 Jun 09:03
 
Change in substantial holding
26 May 08:37
 
View More arrow Created with Sketch.

Featured News

VMM Viridis Selected for BNDES and FINEP Strategic Mineral Funding to Advance Colossus Project
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)
right-arrow Created with Sketch.
WCE West Coast Silver Identifies Shallow High-Grade Mineralisation in Early Drilling
right-arrow Created with Sketch.
NEWS High-Grade Assays Confirm Multiple Parallel Zones at Golden Eye
right-arrow Created with Sketch.
NEWS Vection Launches Algho AI Sign Language on AWS Marketplace Across Europe
right-arrow Created with Sketch.
NEWS Argenica Receives FDA Investigational New Drug Application Update
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
6.7¢ 		Change
-0.001(1.47%) 		Mkt cap ! $108.8M
Open High Low Value Volume
7.8¢ 8.3¢ 6.5¢ $1.693M 23.30M

Buyers (Bids)

No. Vol. Price($)
1 3255 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.8¢ 50000 1
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
SNT (ASX) Chart

Top Stories

Week 24 Wrap: WW3 looms (again); US econ data tepid & silver surfing

By and large, I don't think I'd be without peers when I said the biggest thing that happened this week was on energy markets.
Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing) Welcome to this week’s HotCopperWire, our market watch podcast!Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through all the week’s biggest news headlines @ and what they mean for Aussie investors.In this Week ...
Resolution's dual-listing to 'expedite growth' – and sets stage for NASDAQ foray Resolution Minerals (ASX:RML) is on the verge of listing on the OTCQB @ oft called the @Venture Market” over in the States @ as it looks to @expedite growth” and @unlock value” through the bold U.S. index expansion.Listen to the Ho...
'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits Advance Metals (ASX:AVM) has started its maiden drilling at the Yoquivo Silver-Gold Project in Mexico with a bang...
Clinuvel shares dip, even as CEO comes back from temp leave After Clinuvel's (ASX:CUV) CEO Dr. Philippe Wolgen took time off back in March to respond to an "acute medical condition," it wasn't...

Featured News

WCE West Coast Silver Identifies Shallow High-Grade Mineralisation in Early Drilling
right-arrow Created with Sketch.
NEWS Anson Completes Maiden JORC Mineral Resources Estimate at Green River Lithium Project
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)
right-arrow Created with Sketch.
NEWS Galactica Drilling Program Complete as Blue Star Transitions to Commercial Production
right-arrow Created with Sketch.
NEWS Argenica Receives FDA Investigational New Drug Application Update
right-arrow Created with Sketch.
VMM Viridis Selected for BNDES and FINEP Strategic Mineral Funding to Advance Colossus Project
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.